Thursday, February 17, 2011

Multiple Myeloma

Multiple Myeloma
Multiple Myeloma There were two interesting and important presentations at the American Society of Hematology ASH 2010 Annual Meeting of the E4A03 trial of induction therapy with lenalidomide plus dexamethasone DA with high-dose versus low dose Ld. 38 In short, David Siegel,

No comments:

Post a Comment